Evidence map›Paper›PMID 28068781›Full record

ArticleAIDS research and human retroviruses2017

Complex Subtype Diversity of HIV-1 Among Drug Users in Major Kenyan Cities.

Kamini Gounder, Micah Oyaro, Nagavelli Padayachi, Thando Mbali Zulu, Tulio de Oliveira, John Wylie, Thumbi Ndung'u

Abstract read
In one paragraph

Article in AIDS research and human retroviruses, 2017. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 11 papers.

0numbers the graph read from it
0cells of the map it votes in
11citing papers in PubMed
0.4field-weighted citation impact, top 44% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

11 citing papers in PubMed, 14 citations in OpenAlex.

  1. Review
  2. BeyondFrontiers in genetics · 2026
    Review
  3. Article
  4. Rising role of 3D-printing in delivery of therapeutics for infectious disease.Journal of controlled release : official journal of the Controlled Release Society · 2024
    Review
  5. Article
  6. Article
  7. Article
  8. Article
  9. Article
  10. Article
  11. Observational
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

7 authors at 4 institutions in 5 countries.

Kamini Gounder1 HIV Pathogenesis Programme, Doris Duke Medical Research Institute, Nelson R. Mandela School of Medicine, University of KwaZulu-Natal , Durban, South Africa .
Micah Oyaro3 Immunology Unit, Department of Human Pathology, University of Nairobi , Nairobi, Kenya .
Nagavelli Padayachi1 HIV Pathogenesis Programme, Doris Duke Medical Research Institute, Nelson R. Mandela School of Medicine, University of KwaZulu-Natal , Durban, South Africa .
Thando Mbali Zulu1 HIV Pathogenesis Programme, Doris Duke Medical Research Institute, Nelson R. Mandela School of Medicine, University of KwaZulu-Natal , Durban, South Africa .
Tulio de Oliveira4 School of Laboratory Medicine and Medical Sciences, College of Health Sciences, University of KwaZulu-Natal , Durban, South Africa .
John Wylie6 Department of Medical Microbiology, University of Manitoba , Winnipeg, Canada .
Thumbi Ndung'u1 HIV Pathogenesis Programme, Doris Duke Medical Research Institute, Nelson R. Mandela School of Medicine, University of KwaZulu-Natal , Durban, South Africa .
University of KwaZulu-Natal · ZAAfrica Health Research Institute · ZAUniversity of Manitoba · CAUniversity of Nairobi · KE

Funding

Wellcome Trust 107752/Z/15/Z
6 · The paper itself

Abstract

Drug users are increasingly recognized as a key population driving human immunodeficiency virus (HIV) spread in sub-Saharan Africa. To determine HIV-1 subtypes circulating in this population group and explore possible geographic differences, we analyzed HIV-1 sequences among drug users from Nairobi, Mombasa, and Kisumu in Kenya. We sequenced gag and env from 55 drug users. Subtype analysis from 220 gag clonal sequences from 54 of 55 participants (median = 4/participant) showed that 44.4% were A, 16.7% were C, 3.7% were D, and 35.2% were intersubtype recombinants. Of 156 env clonal sequences from 48 of 55 subjects (median = 3/participant), 45.8% were subtype A, 14.6% were C, 6.3% were D, and 33.3% were recombinants. Comparative analysis of both genes showed that 30 (63.8%) participants had concordant subtypes, while 17 (36.2%) were discordant. We identified one genetically linked transmission pair and two cases of dual infection. These data are indicative of extensive HIV-1 intersubtype recombination in Kenya and suggest decline in subtype D prevalence.

Indexed as

Drug UsersGenetic VariationGenotypeAdolescentAdultCitiesCoinfectionCross-Sectional StudiesDisease Transmission, Infectiousenv Gene Products, Human Immunodeficiency VirusFemalegag Gene Products, Human Immunodeficiency VirusHIV-1HIV InfectionsHumansKenyaenv Gene Products, Human Immunodeficiency Virusgag Gene Products, Human Immunodeficiency Virusdrug usersHIV-1 subtypesintersubtype recombinantsKenya

Identifiers

PMID28068781
PMCPMC5439455
OpenAlexW2570006560

What OpenQuestion holds

Textmetadata
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.